Why Atara Biotherapeutics Stock Is Crashing Today

Shares of the next-generation cell therapy company Atara Biotherapeutics (NASDAQ: ATRA) are getting hammered today. Specifically, the clinical-stage biotech's stock was down by an unsightly 54% as of 3:36 p.m. ET Wednesday.

What's weighing on Atara's share price today? Prior to Wednesday's opening bell, Atara announced that the closely watched multiple sclerosis candidate, known as ATA188, will continue its ongoing phase 2 trial without any changes.

Image source: Getty Images.

Continue reading

Source Fool.com